Drugs Information: Obinutuzumab

Basic Information

ID DDInter1320
Drug Type biotech
Molecular Formula C6512H10060N1712O2020S44
Molecular Weight -
Description Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.
ATC Classification L01XC15
IUPAC Name None
InChI None
InChI Key None
Canonical SMILES None
Useful Links DrugBank

Interactions with Obinutuzumab

Severity level ID Name Mechanism Detail